X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP) UX023-CL401
Research Grant
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Ultragenyx Pharmaceutical
Start Date
September 6, 2018
End Date
June 30, 2028
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Ultragenyx Pharmaceutical
Start Date
September 6, 2018
End Date
June 30, 2028